Popular Trials
Kinase Inhibitor
Vemurafenib + Cobimetinib for Thyroid Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is testing how well vemurafenib and cobimetinib work in treating patients with high-risk thyroid cancer that has a specific genetic mutation. These medications work by blocking abnormal proteins that signal
Radiation
MRI + CT-Guided Radiation Therapy for Sarcoma
Recruiting1 awardPhase 2
Los Angeles, California
"This trial aims to use advanced radiation technology to deliver precise doses of radiation to cancerous tumors while avoiding damage to healthy organs. Participants with sarcoma will receive daily radiation treatment for 5 days a week
Popular Filters
Phase 3 Trials
Antipsychotic
Lumateperone for Bipolar Mania
Recruiting1 awardPhase 3
Garden Grove, California
"This trial is testing a new treatment for patients with bipolar disorder who are experiencing manic episodes. It is a study that involves multiple centers and participants will be randomly assigned to different treatment groups. The study is
Trials With No Placebo
CAR T-cell Therapy
Bria-OTS Immunotherapy for Breast Cancer
Recruiting1 awardPhase 1 & 2
Santa Monica, California
"This trial is testing the safety and effectiveness of a new treatment called the Bria-OTS regimen for patients with certain types of cancer. In the first phase, patients will be treated with the BC1
Behavioral Intervention
Social Facilitation for Emotion Regulation
Recruiting1 award2 criteria
Los Angeles, California
"This trial is testing if adolescents regulate their emotions better and for longer when they have a friend helping them compared to when they do it alone. They will also study how the brain works differently in social versus
Anti-metabolites
Gemcitabine + Leflunomide for Pancreatic Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing whether combining leflunomide with gemcitabine is safe and effective in treating patients with advanced pancreatic cancer that cannot be surgically removed. The goal is to improve the
CAR T-cell Therapy
CAR T Cell Therapy for Acute Lymphoblastic Leukemia
Recruiting1 awardPhase 1
Duarte, California
This trial is testing a new therapy called huCD19-CAR T cell therapy for treating patients with a type of leukemia called B-cell acute lymphoblastic leukemia (ALL) that has not responded to
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.